Rough in Medical Technology

Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline

...le the reduction in errors on a test that measures learning and memory performance versus those who took a placebo," Yurko-Mauro said. "The benefit is roughly equivalent to having the learning and memory skills of someone three years younger." About ICAD 2009 The 2009 Alzheimer's Associat...

Number of Patients With Dementia on the Rise

...ity. They forget their families and friends." roughly 50 percent of people who reach 85 will become d...ikes to 60 percent. Of those who develop dementia, roughly 60 percent will prove to have Alzheimer's disea...s with Alzheimer's disease in the United States is roughly 5 million. By the year 2050, it will grow to ab...

GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting

...S Background HIV affects the entire globe and comes in a variety of subtypes. Clade B is the predominant subtype in North America where there are roughly 60,000 new infections each year. Globally, there are about 2.5 million AIDS infections per year, most primarily involving subtypes AG, B, and C. I...

Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults

... a tendency to have recurrent seizures and defined by two or more unprovoked seizures. There are many different seizure types and epileptic syndromes. roughly 20-30 percent of people living with epilepsy have either uncontrolled seizures or significant side effects secondary to medication. This highlights...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... 72 weeks of treatment evaluated with a nonparametric rank ANCOVA analysis. Both trials enrolled patients in North America, Europe and Australia with roughly 75% of the total 779 patients enrolled in North America. CAPACITY 1 enrolled a total of 344 patients. Patients were randomized 1:1 to recei...

Complications and Costs for Obesity Surgery Declining

...hospitalized for bariatric surgery dropped from approximately 24 percent to roughly 15 percent. Much of this was driven by a reduction in the post-surgical ... 2002. Hospital readmissions because of complications fell 31 percent, from roughly 10 percent to 7 percent, while complication-caused same-day hospital out...

R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges

...e-changing medicines and vaccines - an increase of roughly $2 billion from 2007, according to analyses by ...merica. In fact, PhRMA member companies dedicated roughly 70 percent of their R&D investment domestic...;D spending by biopharmaceutical companies equaled roughly $65,000 per direct employee in 2006 - about eig...

Statins Lower Stroke Severity, Improve Recovery

...ed within 15 days either side of the stroke incident -- and had LDL levels at or below 100 mg/dL, which is considered optimal for healthy individuals. roughly half the cohort of 207 had been taking statins. Researchers also adjusted for age, gender and stroke severity. Others on the research team wer...

American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics'

...pdf ) Symposium Addresses Difficult to Treat Ankle Sprains In the United States, the incidence of ankle sprains is roughly 2,300 a day, almost 100 every hour. Although the majority of acute ankle sprains heal without surgery, approximately 15 to 20 percent of patients ...

MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series

...re difficult to heal, and impair the quality of life of patients due to pain, reduction in daily living capabilities, and issues with odor (1) roughly 1% of the population will have a venous leg ulcer at some point in their lifetime (2) The costs to treat venous leg ulcers in the US exceed...

Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment

...uced diabetic neuropathy and hyperalgesia, or extreme sensitivity to pain. roughly one-third of the rodents were given injections of two calcium channel bl...de) alone and in combination with flupirtine (a potassium channel opener). roughly another third were given a range of doses up to the maximum that would n...

Senetek PLC Launches Dedicated Pyratine-6(TM) Website

...ins for therapeutic applications, and present the results of a 12-week independent clinical trial that demonstrates the efficacy of Pyratine-6(TM) for roughness, erythema, hyperpigmentation, skin moisture, and fine wrinkles. Also featured is Senetek's history in the development of innovative skincare tech...

Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL

...s characterized by the accumulation of functionally immature white blood cells (lymphocytes) in the bone marrow, blood, lymph tissue and other organs. roughly 90,000 people in the United States are living with CLL, according to the Leukemia and Lymphoma Society. More people are living with CLL than any ot...

Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients

...isrupted and loses its ability to produce normal cells. There is no curative treatment for MDS, with the exception of bone marrow transplantation, and roughly 70 percent of all patients with MDS encounter complications or progression due to acute myeloid leukemia. MDS affects all ages, from children to ad...

Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds

...tables, has been proven to reduce mild high blood pressure without medication. The dose of whole table grape powder that was consumed in the study was roughly equivalent to a person eating nine human-sized servings of grapes a day. Currently, five to nine servings of fruits and vegetables are recommended ...

Senate Told Brain Technology Can Impact Public Policy

...recently, we have learned that this can be done in ways that generalize to everyday life and persist after the training ends. These gains are large -- roughly equivalent to a reversal in the normal decline we see over a decade in an average person over age 50." Dr. Mahncke also said that independent stu...

New Research Just Released: Women Can Now Safely Postpone Motherhood Until Time Is Right

...McGill University in Montreal found specifically that the rate of birth defects among the 200 children conceived using vitrified eggs was 2.5 percent, roughly the same as in natural pregnancies and IVF. Because women are born with a finite number of eggs and that supply declines with age, putting off mo...

Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL

...combination) and possibly Rituxan, and had failed to respond to those therapies or suffered a relapse of the disease. The median age was 62 years old. roughly equal numbers of patients were enrolled based on their subtype of lymphoma, which included: DLBCL, follicular lymphoma (FL) and other non-Hodgkin's...

Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting

...lization of disease. Prior to enrollment in this study, all these patients had progressive disease despite standard-of-care hormonal therapies, and in roughly half the patients, also chemotherapy. As opposed to most previous studies in CRPC that have used the RECIST criteria to define evaluable patients a...

Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome

... between diarrhea and constipation. IBS is estimated to afflict approximately 12 percent of the adult population in the United States and Europe, with roughly equal prevalence of each subtype. For reasons that remain unknown, IBS is a female-predominant disorder, with two-thirds to three-quarters of the s...

Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures

...bout deep sternal wound infections Deep sternal wound infections occur in roughly 0.8% to 2% of patients undergoing median sternotomy and CABG. This rate ...G procedures are performed globally each year. The worldwide CABG market is roughly $36 billion. About Derma Sciences Derma Sciences is a global manufac...

Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests

...130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of euro 9.85 billion (on a pro forma basis including Dade Behring roughly euro 11 billion), orders of euro 10.27 billion, and group profit of euro 1.32 billion. Further information can be found by visiting http://www.sie...

Pew Commission Says Industrial Scale Farm Animal Production Poses 'Unacceptable' Risks to Public Health, Environment

...er the past five decades, the number of farms producing animals for food has fallen dramatically, yet the number of food animals produced has remained roughly constant. It is the concentration of farm animals in larger and larger numbers in close proximity to one another, along with the potential of IFAP ...

TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials

...tients treated with the TAXUS Stent versus 336 diabetic patients treated with bare-metal stents (BMS). Three-year rates of TVR and TLR were reduced by roughly 50 percent in diabetic patients treated with the TAXUS Stent compared to BMS, consistent with results seen in other high-risk patient groups. The T...

Metabolex Initiates Phase 1 Trial of MBX-2982

... According to estimates from the ADA, approximately 11 percent of U.S. healthcare dollars are spent on treating diabetes. Type 2 diabetes accounts for roughly 90 to 95 percent of diabetic cases. About Metabolex Metabolex is a privately-held biopharmaceutical company focused on the discovery and develo...

deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases

...e activity of major biological pathways. As a result, these variants place individuals on a spectrum of risk, with most of the population clustered at roughly average risk and a smaller number of people at either significantly higher or lower risk. In today's paper, the deCODE team and collaborators fro...

Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing

...130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of euro 9.85 billion (on a pro forma basis including Dade Behring roughly euro 11 billion), orders of euro 10.27 billion, and group profit of euro 1.32 billion. Further information can be found by visiting http://www.sie...

Physicians Reconsider Implications of Enhance Trial

... -- Despite the controversy surrounding the release of the preliminary ENHANCE trial results on January 14, 2008, physicians are less concerned now -- roughly three weeks later -- about the trial results than they were initially, according to a pivotal FirstImpact Report issued today by FirstWord Publishi...

Data Demonstrate that Obagi Medical Products' Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures

...nt (from severe to mild or moderate to none) in this type of sun damage related discoloration. Similar levels of improvement were also seen in tactile roughness and sallowness. These results are independent of the effects of botulinum toxin type A, therefore supporting the benefit of using the unique Cond...

U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims

...the battle against HIV/AIDS. Gilead markets TDF in the United States under the brand name VIREAD and as a part of its ATRIPLA combination product. roughly 40 million people worldwide are infected with HIV/AIDS, including more than 1.2 million Americans. The U.S. Food and Drug Administration will not a...

New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema

...n and extra dry skin." In a clinical study, 100% of subjects who used the AVEENO(R) Eczema Care Moisturizing Cream twice a day showed improvement in roughness in one week. In a separate clinical study, subjects who used the AVEENO(R) Eczema Care products showed significant improvements in itching and sk...

Not Only Lipids and Inflammation: Insight Into a New Cause of Heart Attack and Other Vascular Disease

... shareholders." Six months ago, deCODE reported that this SNP confers significantly increased risk of coronary artery disease (CAD) and accounts for roughly one- third of early-onset heart attacks. This discovery has now been replicated in studies of ten populations. The study published today was aimed ...

ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke

...ents who experienced dramatic or early clinical recovery were higher in the treatment group compared to controls. Clinical recovery at 24-36 hours was roughly equivalent in both groups as was neurological improvement at 24-36 hours. Clinical evaluations at 90 days post-treatment favored the treatment grou...

Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles

...ket for effective zoster medications will double in size based on the published vaccine efficacy rates and the aging of the baby boomers." "There are roughly one million cases of herpes zoster in the United States annually and current therapy requires multiple dosing, anywhere from three to five times a ...

Obesity Common in Children with Heart Disease

...d one of the hospitals for cardiology outpatient care in 2004. Of the 2,921 samples, 1,523 children had either acquired or congenital heart disease. roughly half of the sample who had no significant heart disease constituted the control group in the study. The rate of overweight and obesity in these con...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation

...ed as a first-line therapy before the patient receives surgery, chemotherapy, or radiotherapy, which is when the immune system is strongest; (3) kills roughly 50% of tumor cells before the standard of care is begun; (4) renders the residual live cancer cells that survive treatment more susceptible to the ...

Roche Diagnostics' HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug

... the Pharmaceuticals Division totaled 33.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.7 billion Swiss francs. Roche employs roughly 75,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Gen...

Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND

...urons degenerate, their ability to send impulses to the muscle fibers is compromised. With an incidence rate of approximately 1 in 10,000, ALS affects roughly 30,000 Americans at any given time. Each year, approximately 5,600 new cases of ALS are diagnosed. The two types of ALS are "sporadic ALS," which a...

Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinson's Disease

...advanced Parkinson's disease. About Parkinson's Disease Parkinson's disease is a progressive disorder of the central nervous system. The patients -- roughly four million worldwide, including approximately one million people in the United States -- suffer primarily from a lack of dopamine, a messenger su...

Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week

...y the Pharmaceuticals Division totaled 33.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.7 billion Swiss francs. Roche employs roughly 75,000 worldwide and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chu...